Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Alpha 1 and Toripalimab in Elderly Patients With Advanced Melanoma
NCT07644897Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2023
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1, toripalimab in melanoma, sponsored by Sun Yat-sen University. Started May 2023; status: recruiting.
02
Drugs
thymosin alpha 1toripalimab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07644897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07644897.